192 related articles for article (PubMed ID: 9059203)
1. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery.
Beyer R; Harmening U; Rittmeyer O; Zielmann S; Mielck F; Kazmaier S; Kettler D
Br J Anaesth; 1997 Jan; 78(1):44-50. PubMed ID: 9059203
[TBL] [Abstract][Full Text] [Related]
2. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution.
Mortelmans YJ; Vermaut G; Verbruggen AM; Arnout JM; Vermylen J; Van Aken H; Mortelmans LA
Anesth Analg; 1995 Dec; 81(6):1235-42. PubMed ID: 7486110
[TBL] [Abstract][Full Text] [Related]
3. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
[TBL] [Abstract][Full Text] [Related]
4. Influence of Two Colloidal Extracorporeal Primes on Coagulation of Cardiac Surgical Patients: A Prospectively Randomized Open-Label Pilot Trial.
Bethlehem I; Wierda K; Visser C; Jekel L; Koopmans M; Kuiper MA
J Extra Corpor Technol; 2014 Dec; 46(4):293-9. PubMed ID: 26357798
[TBL] [Abstract][Full Text] [Related]
5. Randomized study comparing the effects of hydroxyethyl starch solution with Gelofusine on pulmonary function in patients undergoing abdominal aortic aneurysm surgery.
Rittoo D; Gosling P; Burnley S; Bonnici C; Millns P; Simms MH; Smith SR; Vohra RK
Br J Anaesth; 2004 Jan; 92(1):61-6. PubMed ID: 14665554
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery.
Kuitunen A; Suojaranta-Ylinen R; Kukkonen S; Niemi T
Scand J Surg; 2007; 96(1):72-8. PubMed ID: 17461317
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs.
Van der Linden PJ; De Hert SG; Deraedt D; Cromheecke S; De Decker K; Paep R; Rodrigus I; Daper A; Trenchant A
Anesth Analg; 2005 Sep; 101(3):629-634. PubMed ID: 16115963
[TBL] [Abstract][Full Text] [Related]
8. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
Haisch G; Boldt J; Krebs C; Kumle B; Suttner S; Schulz A
Anesth Analg; 2001 Mar; 92(3):565-71. PubMed ID: 11226079
[TBL] [Abstract][Full Text] [Related]
9. Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery.
Winterhalter M; Malinski P; Danzeisen O; Sixt S; Monaca E; Jüttner T; Peiper M; Kienbaum P; Koester A; Rahe-Meyer N
Eur J Med Res; 2010 Sep; 15(9):383-9. PubMed ID: 20952347
[TBL] [Abstract][Full Text] [Related]
10. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.
Gallandat Huet RC; Siemons AW; Baus D; van Rooyen-Butijn WT; Haagenaars JA; van Oeveren W; Bepperling F
Can J Anaesth; 2000 Dec; 47(12):1207-15. PubMed ID: 11132743
[TBL] [Abstract][Full Text] [Related]
11. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage.
Marx G; Cobas Meyer M; Schuerholz T; Vangerow B; Gratz KF; Hecker H; Sümpelmann R; Rueckoldt H; Leuwer M
Intensive Care Med; 2002 May; 28(5):629-35. PubMed ID: 12029413
[TBL] [Abstract][Full Text] [Related]
13. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution.
Ickx BE; Bepperling F; Melot C; Schulman C; Van der Linden PJ
Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617
[TBL] [Abstract][Full Text] [Related]
14. Fluid optimization with hydroxyethyl starch 130/0.4 compared with modified fluid gelatin guided by esophageal Doppler during major abdominal surgeries.
El-Fandy GG; Omar SH; El-Desouky AA; Kamel HH; Refaat AI
J Egypt Soc Parasitol; 2014 Apr; 44(1):151-60. PubMed ID: 24961021
[TBL] [Abstract][Full Text] [Related]
15. Stroke volume optimization after anaesthetic induction: An open randomized controlled trial comparing 0.9% NaCl versus 6% hydroxyethyl starch 130/0.4.
L'Hermite J; Muller L; Cuvillon P; Bousquet PJ; Lefrant JY; de La Coussaye JE; Ripart J
Ann Fr Anesth Reanim; 2013 Oct; 32(10):e121-7. PubMed ID: 23867539
[TBL] [Abstract][Full Text] [Related]
16. Peri-operative tolerance to large-dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin.
Vogt N; Bothner U; Brinkmann A; de Petriconi R; Georgieff M
Anaesthesia; 1999 Feb; 54(2):121-7. PubMed ID: 10215706
[TBL] [Abstract][Full Text] [Related]
17. A change of colloid from hydroxyethyl starch to gelatin does not reduce rate of renal failure or mortality in surgical critical care patients: Results of a retrospective cohort study.
Albrecht FW; Glas M; Rensing H; Kindgen-Milles D; Volk T; Mathes AM
J Crit Care; 2016 Dec; 36():160-165. PubMed ID: 27546766
[TBL] [Abstract][Full Text] [Related]
18. Effects of colloid pre-loading on thromboelastography during elective intracranial tumor surgery in pediatric patients: hydroxyethyl starch 130/0.4 versus 5% human albumin.
Peng Y; Du J; Zhao X; Shi X; Wang Y
BMC Anesthesiol; 2017 Apr; 17(1):62. PubMed ID: 28449710
[TBL] [Abstract][Full Text] [Related]
19. Effect of Hydroxyethyl Starch vs Saline for Volume Replacement Therapy on Death or Postoperative Complications Among High-Risk Patients Undergoing Major Abdominal Surgery: The FLASH Randomized Clinical Trial.
Futier E; Garot M; Godet T; Biais M; Verzilli D; Ouattara A; Huet O; Lescot T; Lebuffe G; Dewitte A; Cadic A; Restoux A; Asehnoune K; Paugam-Burtz C; Cuvillon P; Faucher M; Vaisse C; El Amine Y; Beloeil H; Leone M; Noll E; Piriou V; Lasocki S; Bazin JE; Pereira B; Jaber S; ; Lasocki S; Huet O; Cadic A; Jacob C; Paugam-Burtz C; Restoux A; Ouattara A; Feitita I; Deloge E; Defaye M; Joannes-Boyau O; Carles P; Napolitano G; Monziols S; Futier E; Vignaud M; Paul S; Gahbiche K; Fayon J; Laroche E; Bazin JE; Brandely A; Le Moal C; Lebuffe G; Garot M; Piriou V; Jaber S; Chanques G; Verzilli D; De Jong A; Millot A; Castagnoli A; Leone M; Pastene B; Castelli C; Medam S; Velly L; Vaisse C; Faucher M; Asehnoune K; Samba E; Roquilly A; Le Penndu M; Cuvillon P; Yves Lefrant J; Wira O; Dubout E; Mfam WS; Lescot T; Begneu E; Burey J; Cirilovic T; Beloeil H; Allo G; Pottecher J; Lebas B; Venot C; Rameau JP; Dimache F; Léger PS; El Amine Y
JAMA; 2020 Jan; 323(3):225-236. PubMed ID: 31961418
[TBL] [Abstract][Full Text] [Related]
20. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
